Bone and mineral metabolism in human immunodeficiency virus infection

Journal of Bone and Mineral Research

Volumn 16, Issue 1, 2001, Pages 2-9

  Kuhne C A ^a   Heufelder, A E ^a   Hofbauer, L C ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; VITAMIN D;

BONE MARROW; BONE METABOLISM; CALCIUM HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERCALCEMIA; HYPOCALCEMIA; HYPOGONADISM; IMMUNOMODULATION; MINERAL METABOLISM; MORPHOMETRICS; OSTEOCLAST; PANCYTOPENIA; QUALITY OF LIFE; REVIEW; VIRUS INFECTION;

EID: 0035171443     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.2001.16.1.2     Document Type: Review

References (102)

1. The AIDS epidemic. Considerations for the 21st century
2. HIV disease and the endocrine system
3. Endocrine and metabolic disturbances in human immunodeficiency virus infection and the acquired immune deficiency syndrome
4. Endocrine implications of human immunodeficiency virus infection
5. Ultrastructure of the bone marrow in HIV infection: Evidence of dyshemopoiesis and stromal cell damage
6. Bone marrow examination in patients with AIDS and AIDS-related complex (ARC). Morphologic and in situ hybridization studies
7. Susceptibility of human bone marrow stromal cells to human immunodeficiency virus (HIV)
8. Infection of human marrow stroma by human immunodeficiency virus-1 (HIV-1) is both required and sufficient for HIV-1-induced hematopoietic suppression in vitro: Demonstration by gene modification of primary human stroma
9. Infection of human fibroblasts and osteoblast-like cells with HIV-1
10. Osteoblastic cell lines are not susceptible to HIV-1 infection
11. HIV-Infektion durch kältekonservierte knochentransplantate
12. Host factors and the pathogenesis of HIV-induced disease
13. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis
14. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand
15. Activated T cells support osteoclast formation in vitro
16. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption
17. Tumor necrosis factor-α stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction
18. Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells
19. Bone remodelling in human immunodeficiency virus-1-infected patients. A histomorphometric study
20. Alterations in bone turnover in HIV-positive patients
21. Albumin synthesis and bone collagen formation in human immunodeficiency virus-positive subjects: Differential effects of growth hormone administration
22. Decreased bone formative and enhanced resorptive markers in human immunodeficiency virus infection: Indication of normalization of the bone-remodeling process during highly active antiretroviral therapy
23. Bone mineral density in patients with human immunodeficiency virus infection
24. Symptomatic osteoporosis in two young HIV-positive African women
25. Accelerated bone and mineral loss in HIV-infected patients receiving potent antiretroviral therapy
26. Autopsy findings in the acquired immune deficiency syndrome
27. Disorders of serum calcium in acquired immunodeficiency syndrome
28. Impaired parathyroid hormone release in human immunodeficiency virus infection
29. Altered parathyroid gland function in severely immunocompromised patients infected with human immunodeficiency virus
30. The multifactorial basis for hypocalcemia during sepsis: Studies of parathyroid hormone-vitamin D axis
31. Expression and function of a CD4-like molecule in parathyroid tissue
32. Symptomatic hypoparathyroidism in acquired immunodeficiency syndrome
33. Serum parathyroid hormone concentrations in patients with HIV infection
34. Hypocalcaemia in HIV infection and AIDS
35. Hypercalcemia and disseminated cytomegalovirus infection in the acquired immunodeficiency syndrome
36. Hypercalcemia associated with cytomegalovirus infection in the acquired immunodeficiency virus syndrome
37. Hypercalcemia in a patient with AIDS and Pneumocystis carinii pneumonia
38. Hypercalcemia in a patient with the acquired immuno-deficiency syndrome and Mycobacterium avium intracellulare infection
39. Hypercalcemia: A clue to Mycobacterium avium intracellular infection in a patient with AIDS
40. Vitamin D-mediated hypercalcemia in fungal infection
41. Hypercalcemia associated with infection by Cryptococcus neoformans and Coccidioides immitis
42. Elevated cytokine levels in a patient with AIDS and hypercalcemia: Effects of therapy with pamidronate
43. Hypercalcemia as an early sign of lymphoma in a patient with acquired immunodeficiency syndrome (AIDS)
44. Vitamin D metabolite-mediated hypercalcemia and hypercalciuria in patients with AIDS- and non-AIDS-associated lymphoma
45. Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Serostim Study Group
46. Human growth hormone increases intestinal vitamin D-dependent calcium-binding protein in hypophysectomized rats
47. The effect of growth hormone on parathyroid function in rats
48. Hypercalcemia in an AIDS patient treated with growth hormone
49. Foscarnet-induced hypercalcemia in AIDS
50. Electrolyte and acid-base disorders associated with AIDS: An etiologic review
51. Severe hypocalcemia in AIDS patients treated with foscarnet and pentamidine
52. A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS
53. Foscarnet-induced hypocalcemia and effects of foscarnet on calcium metabolism
54. Symptomatic hypocalcemia and hypomagnesemia with renal magnesium wasting associated with pentamidine therapy in a patient with AIDS
55. Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective randomized trial
56. Subnormal serum concentration of 1,25-vitamin D in human immunodeficiency virus infection: Correlation with degree of immune deficiency and survival
57. Disseminated Mycobacterium avium complex infection in AIDS: Immunopathogenic significance of an activated tumor necrosis factor system and depressed serum levels of 1,25-dihydroxyvitamin D
58. 3 in human immunodeficiency virus infection: Association with immunological hyperactivity and only minor changes in calcium homeostasis
59. Serum levels of tumor necrosis factor-α (TNF-α) and soluble TNF receptors in human immunodeficiency virus type 1 infection - Correlations to clinical, immunologic, and virologic parameters
60. Endocrine function in the HIV wasting syndrome
61. 3 receptors in osteoblastic ROS 17/2.8 cells
62. 3, a novel immunoregulatory hormone
63. Human immunodeficiency virus infection of monoblastoid cells: Cellular differentiation determines the pattern of virus replication
64. 3: Roles of interferon and tumor necrosis factor in regulation of HIV production
65. Enhancement of human immunodeficiency virus 1 replication in monocytes by 1,25-dihydroxy-cholecalciferol
66. 3 inhibits productive infection of human monocytes by HIV-1
67. Proliferation-dependent HIV-1 infection of monocytes occurs during differentiation into macrophages
68. Effect of cellular differentiation on cytokine-induced expression of human immunodeficiency virus in chronically infected promonocytic cells: Dissociation of cellular differentiation and viral expression
69. 3 up-regulates functional CXCR4 human immunodeficiency virus type 1 coreceptors in U937 minus clones: NF-κB- independent enhancement of viral replication
70. Regulation of TNF-α release from bone marrow-derived macrophages by vitamin D
71. Human immunodeficiency virus infection: Musculoskeletal manifestations
72. Clinical manifestations of classical, endemic African, and epidemic AIDS-associated Kaposi's sarcoma
73. Lytic vertebral lesions: An unusual manifestation of AIDS-associated Kaposi's sarcoma
74. Primary intraosseous AIDS-associated Kaposi's sarcoma. Report of two cases with initial jaw involvement
75. Kaposi sarcoma involving bone: CT demonstration in a patient with AIDS
76. Lytic vertebral lesions in a patient with AIDS: A new case of Kaposi's sarcoma involving bones
77. AIDS-related Kaposi's sarcoma involving bone and bone marrow
78. Anaplastic large-cell lymphoma presenting primarily in bone in a patient with AIDS
79. A case of primary bone lymphoma associated with acquired immunodeficiency syndrome
80. Two cases of localized B-cell lymphoma in the acquired immunodeficiency syndrome
81. AIDS-associated secondary lymphoma of bone: A case report with review of the literature
82. Metastatic giant-cell bone tumor in a man positive for HIV
83. Nonsecretory multiple myeloma in a 26-year-old man with acquired immunodeficiency syndrome, presenting with multiple extramedullary plasmacytomas and osteolytic bone disease
84. Pseudoneoplastic infection of bone in acquired immunodeficiency syndrome. A case report involving the cat-scratch disease bacillus
85. Osteolytic lesions and bacillary angiomatosis in HIV infection: Radiologic differentiation from AIDS-related Kaposi sarcoma
86. Bone bacillary angiomatosis in an HIV-infected patient
87. Osseous manifestations of bacillary angiomatosis
88. Considering Mycobacterium haemophilum in the differential diagnosis for lytic bone lesions in AIDS patients who present with ulcerating skin lesions
89. Invasive aspergillosis of the temporal bone: An unusual manifestation of acquired immunodeficiency syndrome
90. Syphilitic osteitis in a patient with secondary syphilis and concurrent human immunodeficiency virus infection
91. Amebic osteomyelitis in a child with acquired immunodeficiency syndrome: A case report
92. Osteoporosis in men
93. Cytokines and estrogen in bone: Anti-osteoporotic effects
94. A unitary model for involutional osteoporosis: Estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men
95. Endocrine disorders in men infected with human immunodeficiency virus
96. Changes in the hypothalamic-pituitary-gonadal axis in human immunodeficiency virus-infected homosexual men
97. Endocrine function in 98 HIV-infected patients: A prospective study
98. Illness stage, concurrent medications, and other correlates of low testosterone in men with HIV illness
99. Evidence for changes in adrenal and testicular steroids during HIV infection
100. Low adrenal androgens in men with HIV infection and the acquired immunodeficiency syndrome
101. Dehydroepiandrosterone as predictor for progression to AIDS in asymptomatic human immunodeficiency virus-infected men
102. The relationship of serum DHEA-S and cortisol levels to measures of immune function in human immunodeficiency virus-related illness